UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 20, 2026
Sale
Calculated transaction value
$141.13K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 19, 2026
Public filing date
Oct 20, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$543.15
Oct 19, 2026
First close after public filing
$563.49
Oct 21, 2026
Return after filing · so far
+4.46%
Through Nov 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 260 shares @ $542.81
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000167
Filing cohort
Transactions in this filing
Showing 15 of 21
Trades
21
Issuers
1
Estimated value
$6.28M
Buys / sales
0 / 19
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $475.01K |
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $306.32K |
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $674.23K |
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $193.09K |
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $22.11K |
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $86.17K |
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $281.52K |
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $581.38K |
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $128.91K |
| United Therapeutics Corp UTHR Current | Sale | Oct 19, 2026 | $141.13K |
| United Therapeutics Corp UTHR | Exercise | Oct 19, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $973.13K |
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $566.69K |
| United Therapeutics Corp UTHR | Sale | Oct 19, 2026 | $44.14K |
| United Therapeutics Corp UTHR | Exercise | Oct 19, 2026 | $0 |